Boston Scientific Corporation (NYSE:BSX) has scheduled a conference call for 28th October 2020 at 8:00 AM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.bostonscientific.com
Earnings Expectation
Boston Scientific Corporation is set to announce third quarter earning results on Wednesday 28th October 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, BSX to report 3Q20 income of $ 0.25 per share. For the full year, analysts anticipate top line of $ 10071.00 million, while looking forward to income of $ 1.01 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 11,809.00 million ~ $ 12,023.00 million, where as bottomline are predicted in a range of $ 1.74 ~ $ 1.79 per share
Click Here For More Historical Outlooks Of Boston Scientific Corporation
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems.
